In tumor development, downregulation of ITIH5 caused by aberrant DNA hypermethylation has been reported in breast cancer [16, 17], bladder cancer [18], colon cancer [19], gastric cancer [20] and lung cancer [21]. Here, ITIH5 is linked to breast carcinoma.